Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses

Mukti Kant Nayak, Anurodh S. Agrawal, Sudeshna Bose, Shaon Naskar, Rahul Bhowmick, Saikat Chakrabarti, Sagartirtha Sarkar, Mamta Chawla-Sarkar

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objectives: Baicalin, a flavonoid, has been shown to have antiviral and anti-inflammatory activities, although the mechanism of action has been unknown. Therefore, attempts were made to analyse the mechanism behind the antiviral effects of baicalin using an influenza A virus (IAV) model in vitro and in vivo. Methods: Baicalin's anti-influenza activity was elucidated (in vitro and in vivo) utilizing pandemic influenza strain A/H1N1/Eastern India/66/pdm09 (H1N1-pdm09). Anti-influenza activity was measured by plaque inhibition, fluorescent focus-forming units (ffu) and quantifying viral transcripts using quantitative real-time PCR following treatment with baicalin in a dose-and time-dependent manner. The role of the IAV non-structural protein 1 (NS1) gene in modulating host responses was measured by immunoblotting, co-immunoprecipitation and molecular docking. Results: Baicalin treatment following IAV infection revealed up-regulation of interferon (IFN)-induced antiviral signalling and decreased phosphoinositide 3-kinase/Akt (PI3K/Akt) activation compared with infected, untreated controls. Baicalin exerts its antiviral effects by modulating the function of the IAV-encoded NS1 protein. NS1 has been shown to counteract cellular antiviral responses by down-regulating IFN induction and up-regulating PI3K/ Akt signalling. Baicalin disrupted NS1-p85b binding. Molecular docking predicted the binding site of baicalin in the RNA binding domain (RBD) of NS1. Site-directed mutagenesis within the RBD region of NS1 and the difference in the fluorescence quenching pattern of full-length NS1 and mutant NS1 proteins in the presence of baicalin confirmed the interaction of baicalin with the NS1 RBD. Amino acid residues 39-43 of the NS1 RBD were found to be crucial for the baicalin-NS1 interaction Conclusions: Overall, this study highlights that baicalin exerts its anti-influenza virus activity by modulati g viral protein NS1, resulting in up-regulation of IFN-induced antiviral signalling and a decrease in PI3K/Akt signalling in cells

Original languageEnglish (US)
Article numberdkt534
Pages (from-to)1298-1310
Number of pages13
JournalJournal of Antimicrobial Chemotherapy
Volume69
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Orthomyxoviridae
Innate Immunity
Cellular Immunity
Antiviral Agents
India
Proteins
Influenza A virus
Interferons
Human Influenza
1-Phosphatidylinositol 4-Kinase
baicalin
Up-Regulation
Viral Nonstructural Proteins
Viral Structural Proteins
Pandemics
Virus Diseases
Mutant Proteins
Site-Directed Mutagenesis
Phosphatidylinositol 3-Kinases
Immunoprecipitation

Keywords

  • Anti-influenza virus
  • Flavonoids
  • Interferons
  • Non-structural protein 1
  • PI3K/Akt

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Nayak, M. K., Agrawal, A. S., Bose, S., Naskar, S., Bhowmick, R., Chakrabarti, S., ... Chawla-Sarkar, M. (2014). Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses. Journal of Antimicrobial Chemotherapy, 69(5), 1298-1310. [dkt534]. https://doi.org/10.1093/jac/dkt534

Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses. / Nayak, Mukti Kant; Agrawal, Anurodh S.; Bose, Sudeshna; Naskar, Shaon; Bhowmick, Rahul; Chakrabarti, Saikat; Sarkar, Sagartirtha; Chawla-Sarkar, Mamta.

In: Journal of Antimicrobial Chemotherapy, Vol. 69, No. 5, dkt534, 2014, p. 1298-1310.

Research output: Contribution to journalArticle

Nayak, MK, Agrawal, AS, Bose, S, Naskar, S, Bhowmick, R, Chakrabarti, S, Sarkar, S & Chawla-Sarkar, M 2014, 'Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses', Journal of Antimicrobial Chemotherapy, vol. 69, no. 5, dkt534, pp. 1298-1310. https://doi.org/10.1093/jac/dkt534
Nayak, Mukti Kant ; Agrawal, Anurodh S. ; Bose, Sudeshna ; Naskar, Shaon ; Bhowmick, Rahul ; Chakrabarti, Saikat ; Sarkar, Sagartirtha ; Chawla-Sarkar, Mamta. / Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses. In: Journal of Antimicrobial Chemotherapy. 2014 ; Vol. 69, No. 5. pp. 1298-1310.
@article{7ad141cb1d9c4737a3737f1609603c5e,
title = "Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses",
abstract = "Objectives: Baicalin, a flavonoid, has been shown to have antiviral and anti-inflammatory activities, although the mechanism of action has been unknown. Therefore, attempts were made to analyse the mechanism behind the antiviral effects of baicalin using an influenza A virus (IAV) model in vitro and in vivo. Methods: Baicalin's anti-influenza activity was elucidated (in vitro and in vivo) utilizing pandemic influenza strain A/H1N1/Eastern India/66/pdm09 (H1N1-pdm09). Anti-influenza activity was measured by plaque inhibition, fluorescent focus-forming units (ffu) and quantifying viral transcripts using quantitative real-time PCR following treatment with baicalin in a dose-and time-dependent manner. The role of the IAV non-structural protein 1 (NS1) gene in modulating host responses was measured by immunoblotting, co-immunoprecipitation and molecular docking. Results: Baicalin treatment following IAV infection revealed up-regulation of interferon (IFN)-induced antiviral signalling and decreased phosphoinositide 3-kinase/Akt (PI3K/Akt) activation compared with infected, untreated controls. Baicalin exerts its antiviral effects by modulating the function of the IAV-encoded NS1 protein. NS1 has been shown to counteract cellular antiviral responses by down-regulating IFN induction and up-regulating PI3K/ Akt signalling. Baicalin disrupted NS1-p85b binding. Molecular docking predicted the binding site of baicalin in the RNA binding domain (RBD) of NS1. Site-directed mutagenesis within the RBD region of NS1 and the difference in the fluorescence quenching pattern of full-length NS1 and mutant NS1 proteins in the presence of baicalin confirmed the interaction of baicalin with the NS1 RBD. Amino acid residues 39-43 of the NS1 RBD were found to be crucial for the baicalin-NS1 interaction Conclusions: Overall, this study highlights that baicalin exerts its anti-influenza virus activity by modulati g viral protein NS1, resulting in up-regulation of IFN-induced antiviral signalling and a decrease in PI3K/Akt signalling in cells",
keywords = "Anti-influenza virus, Flavonoids, Interferons, Non-structural protein 1, PI3K/Akt",
author = "Nayak, {Mukti Kant} and Agrawal, {Anurodh S.} and Sudeshna Bose and Shaon Naskar and Rahul Bhowmick and Saikat Chakrabarti and Sagartirtha Sarkar and Mamta Chawla-Sarkar",
year = "2014",
doi = "10.1093/jac/dkt534",
language = "English (US)",
volume = "69",
pages = "1298--1310",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses

AU - Nayak, Mukti Kant

AU - Agrawal, Anurodh S.

AU - Bose, Sudeshna

AU - Naskar, Shaon

AU - Bhowmick, Rahul

AU - Chakrabarti, Saikat

AU - Sarkar, Sagartirtha

AU - Chawla-Sarkar, Mamta

PY - 2014

Y1 - 2014

N2 - Objectives: Baicalin, a flavonoid, has been shown to have antiviral and anti-inflammatory activities, although the mechanism of action has been unknown. Therefore, attempts were made to analyse the mechanism behind the antiviral effects of baicalin using an influenza A virus (IAV) model in vitro and in vivo. Methods: Baicalin's anti-influenza activity was elucidated (in vitro and in vivo) utilizing pandemic influenza strain A/H1N1/Eastern India/66/pdm09 (H1N1-pdm09). Anti-influenza activity was measured by plaque inhibition, fluorescent focus-forming units (ffu) and quantifying viral transcripts using quantitative real-time PCR following treatment with baicalin in a dose-and time-dependent manner. The role of the IAV non-structural protein 1 (NS1) gene in modulating host responses was measured by immunoblotting, co-immunoprecipitation and molecular docking. Results: Baicalin treatment following IAV infection revealed up-regulation of interferon (IFN)-induced antiviral signalling and decreased phosphoinositide 3-kinase/Akt (PI3K/Akt) activation compared with infected, untreated controls. Baicalin exerts its antiviral effects by modulating the function of the IAV-encoded NS1 protein. NS1 has been shown to counteract cellular antiviral responses by down-regulating IFN induction and up-regulating PI3K/ Akt signalling. Baicalin disrupted NS1-p85b binding. Molecular docking predicted the binding site of baicalin in the RNA binding domain (RBD) of NS1. Site-directed mutagenesis within the RBD region of NS1 and the difference in the fluorescence quenching pattern of full-length NS1 and mutant NS1 proteins in the presence of baicalin confirmed the interaction of baicalin with the NS1 RBD. Amino acid residues 39-43 of the NS1 RBD were found to be crucial for the baicalin-NS1 interaction Conclusions: Overall, this study highlights that baicalin exerts its anti-influenza virus activity by modulati g viral protein NS1, resulting in up-regulation of IFN-induced antiviral signalling and a decrease in PI3K/Akt signalling in cells

AB - Objectives: Baicalin, a flavonoid, has been shown to have antiviral and anti-inflammatory activities, although the mechanism of action has been unknown. Therefore, attempts were made to analyse the mechanism behind the antiviral effects of baicalin using an influenza A virus (IAV) model in vitro and in vivo. Methods: Baicalin's anti-influenza activity was elucidated (in vitro and in vivo) utilizing pandemic influenza strain A/H1N1/Eastern India/66/pdm09 (H1N1-pdm09). Anti-influenza activity was measured by plaque inhibition, fluorescent focus-forming units (ffu) and quantifying viral transcripts using quantitative real-time PCR following treatment with baicalin in a dose-and time-dependent manner. The role of the IAV non-structural protein 1 (NS1) gene in modulating host responses was measured by immunoblotting, co-immunoprecipitation and molecular docking. Results: Baicalin treatment following IAV infection revealed up-regulation of interferon (IFN)-induced antiviral signalling and decreased phosphoinositide 3-kinase/Akt (PI3K/Akt) activation compared with infected, untreated controls. Baicalin exerts its antiviral effects by modulating the function of the IAV-encoded NS1 protein. NS1 has been shown to counteract cellular antiviral responses by down-regulating IFN induction and up-regulating PI3K/ Akt signalling. Baicalin disrupted NS1-p85b binding. Molecular docking predicted the binding site of baicalin in the RNA binding domain (RBD) of NS1. Site-directed mutagenesis within the RBD region of NS1 and the difference in the fluorescence quenching pattern of full-length NS1 and mutant NS1 proteins in the presence of baicalin confirmed the interaction of baicalin with the NS1 RBD. Amino acid residues 39-43 of the NS1 RBD were found to be crucial for the baicalin-NS1 interaction Conclusions: Overall, this study highlights that baicalin exerts its anti-influenza virus activity by modulati g viral protein NS1, resulting in up-regulation of IFN-induced antiviral signalling and a decrease in PI3K/Akt signalling in cells

KW - Anti-influenza virus

KW - Flavonoids

KW - Interferons

KW - Non-structural protein 1

KW - PI3K/Akt

UR - http://www.scopus.com/inward/record.url?scp=84898460639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898460639&partnerID=8YFLogxK

U2 - 10.1093/jac/dkt534

DO - 10.1093/jac/dkt534

M3 - Article

VL - 69

SP - 1298

EP - 1310

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 5

M1 - dkt534

ER -